*Enrollment for this study is currently closed. Anyone who has already signed the consent form is encouraged to continue their study participation*
About the Study: MGB PROTECTS is a 12-month research study to determine the prevalence of antibodies against COVID-19 in Mass General Brigham employees who have have signed a consent form to be in the study and do not have symptoms associated with COVID-19 infection.
During the initial (pilot) portion of the study we will enroll approximately 500 participants prior to launching the full study. The initial portion of the study is intended to be identical to the main study. The reason we are conducting an initial portion of the study is to ensure all systems are in place to successfully identify subjects, and to ensure the usability and quality of testing material when shipped to participants. We will also use this initial portion of the study to ensure that appropriate follow-up systems are in place for participants that have positive antibody tests and to understand how best to return test results to participants.
What should I do if I am interested in joining the study?
- Read about the study
- Read through the consent form
- After reading the consent form, sign if you are still interested and agree to join the study.
- If you have any questions at any point, please contact us by calling (617) 525-6700 or emailing Biobank@partners.org
What will happen after I sign the consent form?
- You will be asked to fill out the first questionnaire right after you sign the consent form.
- You will receive the first kit in the mail.
- Follow the directions to take a small blood sample (like a pinprick) using the provided equipment.
- Mail back the kit.
- You will be asked to complete 3 more questionnaires during the study. You will receive at least one more kit for testing your blood at the end of the study (at approximately Month 12).
- We may send you additional kits to test your blood up to two more times within the year, if your first antibody results are positive, or if you should tell us in any of the follow-up questionnaires that you have developed symptoms of COVID-19.
*Enrollment for this study is currently closed. Anyone who has already signed the consent form is encouraged to continue their study participation*